©The Author(s) 2016.
World J Gastroenterol. Mar 28, 2016; 22(12): 3341-3354
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3341
Table 1 Clinicopathological data of the hepatocellular carcinoma cohort
| Clinicopathologic parameters | Frequency | % |
| All cases | 30 | |
| Gender | ||
| Male | 23 | 76.7 |
| Female | 7 | 23.3 |
| Age (yr) | ||
| < 50 | 5 | 16.7 |
| > 50 | 25 | 83.3 |
| Tumor size (cm) | ||
| < 5 | 8 | 26.7 |
| > 5 | 22 | 73.3 |
| Serum HBsAg | ||
| Positive | 24 | 80.0 |
| Negative | 6 | 20.0 |
| Serum AFP (ng/mL) | ||
| < 25 | 4 | 13.3 |
| > 25 | 26 | 86.7 |
| Cirrhosis | ||
| Presence | 27 | 90.0 |
| Absence | 3 | 10.0 |
| UICC stage | ||
| I + II | 13 | 43.3 |
| III + IV | 17 | 56.7 |
| Metastasis/Recurrence | ||
| Yes | 18 | 60.0 |
| No | 12 | 40.0 |
| Edmondson grade | ||
| Low (I/II) | 10 | 33.3 |
| High (III/IV) | 20 | 66.7 |
- Citation: Peng R, Zhao GX, Li J, Zhang Y, Shen XZ, Wang JY, Sun JY. Auphen and dibutyryl cAMP suppress growth of hepatocellular carcinoma by regulating expression of aquaporins 3 and 9 in vivo. World J Gastroenterol 2016; 22(12): 3341-3354
- URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3341